Company

Cancer’s Vulnerability is Our Strength

MANAGEMENT

Markus Renschler, MD
Markus Renschler, MDPresident & Chief Executive Officer
Susan Doleman
Susan DolemanVP, Clinical Operations
Paul Secrist, PhD
Paul Secrist, PhDChief Scientific Officer
Lisa Hayes
Lisa HayesVP, Investor Relations and Corporate Communications
Barbara Wan, PhD
Barbara Wan, PhDVP, Research & Development Project Leadership
Tom O'Shea, PhD
Tom O'Shea, PhDSVP, Clinical Pharmacology and Preclinical Development
Judson Englert, MD, PhD
Judson Englert, MD, PhDVP, Clinical Research & Development
Jean-Marc Lapierre, PhD
Jean-Marc Lapierre, PhDVP, Chemistry
Andrew Gengos
Andrew GengosChief Business Officer
David Gaiero
David GaieroVP, Finance

BOARD OF DIRECTORS

Racquel Bracken
Racquel BrackenVenrock
Markus Renschler, MD
Markus Renschler, MDPresident & Chief Executive Officer
Joseph S. Zakrzewski
Joseph S. ZakrzewskiIndependent Investor & Chairman, Cyteir Therapeutics
Jean George, MBA
Jean George, MBALightstone Ventures
Timothy Romberger
Timothy RombergerFounder Cyteir Therapeutics & TRC Advisory
Susan Molineaux, PhD
Susan Molineaux, PhDPresident and CEO of Calithera Biosciences
Karen Hong, PhD
Karen Hong, PhDNovo Ventures
Janwillem Naesens, MSc, MBA
Janwillem Naesens, MSc, MBADROIA